RIO DE JANEIRO, BRAZIL - The American pharmaceutical company Pfizer has signed UN-sponsored licensing agreements with 35 laboratories, allowing the manufacture of a generic and cheaper version of its treatment against covid-19, according to an announcement on March 17. Brazil is one of the countries covered.
Under the terms of an agreement reached with Subscribe to our Premium Membership Plan. Already Subscribed? Login Here